FDA Investigator Deborah G Haney Cozzone

Deborah G Haney Cozzone has inspections in 2 countries as of 07 Sep 2023. Deborah G Haney Cozzone has collaborated with a combinined 2026 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
347
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada
Co-Investigator(s):
Abdellah El Hajjam, Alan D Centi, Alissa E Berryman, Amy L Mcintyre, Andrew J Howard, Anita R Michael, Ann Marie Karnick, Audrey Thereset Uy, Beichner, Brandi L Garbutt, Brandon J Brookens, Brian D Young, Brian M Palermo, Calvin W Edwards, CDR Michael J Mero, Celia L Hutchinstein, Chamberlain, Christopher L Taste, Christopher R Richardson, Chyla T Hunter, Crayton, Crayton Lee, Cynthia White, Daniel W Johnson, Darlene C Plank Turlington, Dauksism, David A Schwartz, David J Hafner, David L Pearce, Dawn D Aiello, Deborah H Cozzone, Debra J Bennett, Derek S Dealy, Devon Jenkins, Donald W Myrick, Dr. Mark J Seaton, PhD, Edward D Mcdonald, Edwin L Hobbs, Eric Rothschild, Eric S Myskowski, Erik A Bungo, Erika M Wilkerson, Gayle S Lawson, Gerald W Kopp, German Rivera, Gess, Giovanni A Vigilante, Gregory E Beichner, Hamiltonl, Haney, Jacqueline Johnson, James M Odonnell, James P Mcevoy, Jason M Sluzynski, Jeen S Min, Jessica M Monteiro, Joseph Brady, Joseph L Despins, PhD, Joseph S Fanelli, Joseph T Dougherty, Joshua C Schafer, Judith A Paterson, Julianne C Mccullough, Justin B Holder, Karen A Spencer, Kim G Campbell, Kyle S Hobson, LCDR Margaret E Digennaro, LCDR Susan E Polifko, Linda M Hoover, Linda M Ross, LT John M Mastalski, LTJG Lauren N Shade, Luis A Dasta, Magdi A Ali, Marc A Jackson, Jr, Marjorie L Davis, Martha Sullivan Myrick, Marybet Lopez, Mastalskij, Matther R Noonan, Matthew R Noonan, Maureen A Wentzel, Melissa M Schafer, Meredith L Sheridan, Michael A Taylor, Michael D Omeara, Michael J Nerz, Michael Rosner, Michele M Falchek, Myrick, Nicole J Clausen, O'meara, Osama M Hamoud, Princess R Campbell, Ramanda C Gregory, Richard E Jewell, Robert J Waldorf, Ronald A Stokes, Ronald T Colucci, Russell P Vandermark, Ruth A Oni, Sean D Duke, Seng Ching Hwang, Sidney M Smith, State Agency, Stephanie Mangigian, MS/OSH, RN, Thomas E Friel, Thompsonv, Timothy J Schmidt, Todd J Maushart, Tonya O Corbin, Upendra Paudel, Van Cliff, Whitney S Reynolds, William C Brenneman, Xinyi Hui, Yessika Mashinski

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more